31 results
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
16 May 24
Departure of Directors or Certain Officers
4:27pm
, Urology and Medical Dermatology, most notably Botox for all therapeutic uses from February 2014 to May 2019. Mr. Forth has held various leadership roles
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
government shut downs, or other disruptions to these agencies’ operations, could hinder their ability to hire and retain key leadership and other
8-K
aznezv41
17 Apr 24
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-99.3
crey3vm
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K
EX-99.1
uixsvq
24 Jul 23
Corporate Presentation July 2023
6:43am
425
EX-99.1
fja82xq
23 May 23
Business combination disclosure
9:39pm
8-K
EX-99.1
mrl3j5rlq lfh1cq
23 May 23
Corporate Presentation May 2023
9:38pm
DEFM14A
7ymol7qc0dw8q34onry
12 May 23
Proxy related to merger
5:00pm
424B3
9g1ar00w
12 May 23
Prospectus supplement
4:33pm